Comparison · NCT02759120-deaths
Antimicrobial Therapy Plus Standard of Care vs Standard of Care: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Antimicrobial Therapy Plus Standard of Care vs Standard of Care: deaths from any cause. Trial comparisons, record NCT02759120-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02759120-deaths
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.146 | 0.108 | 0.194 | wilson | |
| Risk in group 2 | 0.143 | 0.105 | 0.191 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00281 | -0.0584 | 0.0642 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.02 | 0.669 | 1.55 | log | |
| Odds ratio, group 1 over group 2 | 1.02 | 0.625 | 1.67 | log | |
| Number needed to harm, for one more death from any cause on Antimicrobial Therapy Plus Standard of Care than on Standard of Care | 356 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: standard of care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Antimicrobial Therapy Plus Standard of Care | Co-trimoxazole OR doxycycline~Antimicrobial therapy: Co-trimoxazole or Doxycycline: 160mg trimethoprim/800mg sulfamethoxazole (double strength co-trimoxazole) twice daily plus folic acid 5 mg daily OR doxycycline 100mg once daily if weight \< 50 kilograms or 100mg twice daily if weight \> 50 kilograms for up to 36 months | 37 | 254 | EG000 |
| Group 2 | Standard of Care | Standard of care for patients with IPF for comparison~No Intervention: Standard of Care: Standard of care | 37 | 259 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, all-cause mortality
- Time frame
- Thirty-five months
Source ClinicalTrials.gov
Trial
- Title
- CleanUP IPF for the Pulmonary Trials Cooperative
- NCT number
- NCT02759120
- Phases
- PHASE3
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Antimicrobial therapy: Co-trimoxazole or Doxycycline, No Intervention: Standard of Care
- Lead sponsor
- Weill Medical College of Cornell University
- Results first posted
- 2021-03-03
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02759120?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02759120-deaths